Australia vs South-East Asia (WHO region): Treatment success rate: XDR-TB cases
Australia
100
in 2022
South-East Asia (WHO region)
73
in 2022
Australia rank
1st
South-East Asia (WHO region) rank
2nd
Treatment success rate: XDR-TB cases over time
- Australia
- South-East Asia (WHO region)
How they compare
Australia currently reports 100 against 73 in South-East Asia (WHO region), a difference of 27.
That makes Australia's figure about 1.4 times South-East Asia (WHO region)'s.
The two have swapped places 2 times across 6 shared years of data; in 2014 it was Australia ahead.
Australia ranks 1st and South-East Asia (WHO region) ranks 2nd of 82 countries.
Australia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 89 | 38 | 51 | Australia |
| 2020s | 77.67 | 69 | 8.67 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Australia or South-East Asia (WHO region)?
- Australia, at 100 against 73 in South-East Asia (WHO region) as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Australia and South-East Asia (WHO region)?
- 27, with Australia ahead.
- How many years of comparable data are there for Australia and South-East Asia (WHO region)?
- 6 years are reported by both, from 2014 to 2022.
- How do Australia and South-East Asia (WHO region) rank globally for treatment success rate: xdr-tb cases?
- Australia ranks 1st and South-East Asia (WHO region) ranks 2nd of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.